<GlossaryTerm id="CDR0000762205"><TermName>Idamycin PFS</TermName><TermPronunciation>(I-duh-MY-sin ...)</TermPronunciation><TermDefinition><DefinitionText>A drug used
          with other drugs to treat adults with acute myeloid
          leukemia. It is also being studied in the treatment of
          other types of cancer. Idamycin PFS
          blocks a certain enzyme needed for cell division and DNA
          repair and may kill cancer cells. It is a type of
          anthracycline antibiotic and a type of topoisomerase
          inhibitor. Also called 4-demethoxydaunorubicin and idarubicin hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000764472" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Idamycin PFS&quot;" language="en" id="_5"/><MediaLink ref="CDR0000764471" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Idamycin PFS&quot;" language="es" id="_6"/><SpanishTermName>Idamycin PFS</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa con
otros medicamentos para el tratamiento de adultos con leucemia mieloide aguda.
También está en estudio para el tratamiento de otros tipos
de cáncer. Idamycin PFS bloquea cierta enzima
necesaria para la multiplicación celular y la reparación
del ADN, y es posible que destruya células cancerosas. Es un
antibiótico de tipo antraciclina y un tipo de inhibidor
de la topoisomerasa. También se llama 4-demetoxidaunorrubicina y clorhidrato de idarrubicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-08-15</DateFirstPublished><DateLastModified>2021-02-12</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000762190" url="/about-cancer/treatment/drugs/idarubicinhydrochloride">Idarubicin Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
